Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
The Laboratory of Neural Stem Cells, led by Professor Hongyan Wang, Acting Director of the Neuroscience & Behavioral Disorders Program at Duke-NUS Medical School, Singapore, is seeking talented and
-
Limited. The Knowledge Transfer Partnership project will focus on developing technically and commercially viable gas diffusion layers for high-volume applications using recycled carbon fibre, creating a
-
seed development first evolved from a seedless vascular plant. Specifically, this project will test whether seed gene networks are conserved with those of the gametophyte egg-chamber (archegonium
-
, techniques or methods and ability to contribute to developing new ones Ability to assess resource requirements and use resources effectively Contribute to the planning and organising of the research programme
-
to: rhizosphere and phyllosphere microbiology microbial evolution molecular and/or structural aspects of plant-microbe or plant-fungal interactions the molecular biology of soil-dwelling bacteria or fungi
-
strategy focuses on its five scientific programmes. GOS ICH's activities include active engagement with children and families, to ensure that our work is relevant and appropriate to their needs. GOS ICH
-
English proficiency (minimum CEFR B22, also checked at interview). A draft Individual Career Development Plan (ICDP). Two reference letters. Any additional documents to support the application. Ethical
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
the following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection
-
approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer or metabolic disease